Skip to main content

Table 1 Mean Visual Analog Scale (VAS) and National Cancer Institute Common Toxicity Criteria for Diarrhea scores and standard deviation on day 0 and day 14 of FEC60 regimen in 10 breast cancer patients who experienced diarrhea during the FEC60 cycle

From: The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study

Scale

Day 0

Day 14

p

VAS (0–10)

1.6 ± 0.3

3.4 ± 0.5

0.014

NCIC (0–4)

1.2 ± 0.9

1.9 ± 0.8

0.005